BEIJING, Feb. 28, 2012 /PRNewswire-Asia-FirstCall/ --
Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier" or
the "Company"), an emerging leader in the development, assembly,
marketing and sale of medical devices and homecare medical
products, today announced that the Company's growing business
earned a BBB+ Credit Rating from the Beijing Zhongguancun
Enterprises Credit Promotion Association (the "Zhongguancun
Association") and was approved as a member of the association.
(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO
)
BBB+ rating reflects Dehaier's competitiveness in the industry,
relatively strong enterprise system, sustainable business model,
rapid growth, profitability and low credit risk.
The Association is managed by Beijing Zhongguancun Sci-Tech
Guaranty Co., Ltd (the "Zhongguancun Guaranty Company"),
established in 1999. Zhongguancun Guaranty Company is a
policy-based credit guaranty organization funded by the Chinese
government and one of China's most
influential domestic guaranty organizations. The National
Development and Reform Committee of Beijing has chosen the Zhongguancun Guaranty
Company as China's national
guaranty organization innovation training base. The Zhongguancun
Guaranty Company provides enterprises with different credit
guaranty ratings and is the guarantor responsible for the
organizations that extend credit to the enterprises according to
rating results.
Dehaier Medical obtained the approval and high rating as a
result of its strong reputation within the corporate and medical
community in Beijing and healthy
financial position.
Mr. Ping Chen, Chairman and Chief
Executive Officer of Dehaier Medical stated, "We are very pleased
to have received this acknowledgement from such a well-known agency
in Beijing. Since our inception,
our company has made a commitment to hold itself to the highest
standard of corporate governance and creditworthiness. We remain
devoted to building a highly transparent, open, and
trustworthy listed firm."
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly,
marketing and sale of medical products, including respiratory and
oxygen homecare medical products. The company develops and
assembles its own branded medical devices and homecare medical
products from third-party components. The company also distributes
products designed and manufactured by other companies, including
medical devices from IMD (Italy),
Welch Allyn (USA), HEYER
(Germany), Timesco (UK), eVent
Medical (US) and JMS (Japan).
Dehaier's technology is based on six patents and five software
copyrights; additionally Dehaier has two pending software
copyrights and proprietary technology. More information may be
found at http://www.dehaier.com.cn.
Forward-looking Statements
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events, government approvals
or performance, and underlying assumptions and other statements
that are other than statements of historical facts, including in
particular statements about Dehaier's membership in the
Zhongguancun Association and the meaning of and retention of any
ratings granted to Dehaier (including any factors affecting such
ratings). These statements are subject to uncertainties and risks
including, but not limited to, product and service demand and
acceptance, changes in technology, economic conditions, the impact
of competition and pricing, government regulation, future
developments in payment for and demand for medical equipment and
services, implementation of and performance under the joint venture
agreement by all parties, and other risks contained in reports
filed by the company with the Securities and Exchange Commission.
All such forward-looking statements, whether written or oral, and
whether made by or on behalf of the company, are expressly
qualified by the cautionary statements and any other cautionary
statements which may accompany the forward-looking statements. In
addition, the company disclaims any obligation to update any
forward-looking statements to reflect events or circumstances after
the date hereof.
Contact Us
Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn
Dehaier Medical Systems Limited
Tina He
+86 10-5166-0080
hexw@dehaier.com.cn
The Equity Group Inc.
Katherine Yao
+86 10-6587-6435
kyao@equityny.com
In America
The Equity Group Inc.
Adam Prior
(212) 836-9606
aprior@equityny.com
SOURCE Dehaier Medical Systems Ltd.